Repair Biotechnologies

Syracuse, NY · Founded 2018 · Privately Held (backing)

Operator of a preclinical biotechnology company intended to develop drugs for cholesterol and aging-related diseases. Repair Biotechnologies is based in Syracuse, NY and was founded in 2018. It was valued at $74.4 million at its seed round in Nov 2025, the last priced event on record. It has raised $22.9 million across 6 recorded rounds; the latest was a $5.3 million early-stage round in Nov 2025.

PMV mark · valuation
$74.4M
Oct 2026
Priced at
its seed round
Nov 2025
Total raised
$22.9M
Last round
Early Stage VC
Nov 2025
Cap table — not yet on record

Repair Biotechnologies's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Repair Biotechnologies with a free account
  • ·The complete investor list: 14 names
  • ·Watch Repair Biotechnologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Repair Biotechnologies

Where does Repair Biotechnologies's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Repair Biotechnologies's 6 recorded funding rounds.